Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biostate in Paediatric Haemophilia A
NCT01229007Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Aug 2010
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
Phase 3, open-label, single-arm trial of factor viii + von Willebrand factor in hemophilia A, sponsored by CSL Limited. Primary endpoints: Subjective assessment of Haemostatic efficacy, Incremental recovery of FVIII at Day 1 and 2 more. Started Aug 2010; status: completed.
02
Drugs
factor viii + von Willebrand factor
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01229007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229007.